User profiles for Massimo Mariani
Massimo MarianiFull Professor of Corporate Finance, LUM University Verified email at lum.it Cited by 856 |
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
…, N D'Agostino, L Miorin, S Buccato, M Mariani… - Science, 2005 - science.org
Group B Streptococcus (GBS) is a multiserotype bacterial pathogen representing a major
cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we …
cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we …
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the …
…, K Wolschleger, J Heiser, P van der Harst, MA Mariani… - The Lancet, 2019 - thelancet.com
Background The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was
a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-…
a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-…
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae
…, C Brettoni, G Galli, M Mariani… - Proceedings of the …, 2002 - National Acad Sciences
The 2,160,267 bp genome sequence of Streptococcus agalactiae, the leading cause of
bacterial sepsis, pneumonia, and meningitis in neonates in the US and Europe, is predicted to …
bacterial sepsis, pneumonia, and meningitis in neonates in the US and Europe, is predicted to …
Extending the benefits of ESG disclosure: The effect on the cost of debt financing
In recent years, greater attention has been paid to sustainability issues. Companies have
received increasing pressure from stakeholders to adopt sustainable behavior and provide an …
received increasing pressure from stakeholders to adopt sustainable behavior and provide an …
Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients
…, SK Bulstra, E Vellenga, MA Mariani… - Circulation: Heart …, 2018 - Am Heart Assoc
Background The most commonly used definition of iron deficiency (ID; ferritin <100 ng/mL or
ferritin 100–300 ng/mL and transferrin saturation [TSAT] <20%) has not been validated in …
ferritin 100–300 ng/mL and transferrin saturation [TSAT] <20%) has not been validated in …
Current management of postoperative chylothorax
H Fahimi, FP Casselman, MA Mariani… - The Annals of thoracic …, 2001 - Elsevier
Background. This study was performed to review our experience with postoperative chylothorax
and describe our current approach. In addition, we wanted to estimate the impact of …
and describe our current approach. In addition, we wanted to estimate the impact of …
Genomic Approach for Analysis of Surface Proteins in Chlamydia pneumoniae
…, O Finco, R Petracca, G Galli, M Mariani… - Infection and …, 2002 - Am Soc Microbiol
Chlamydia pneumoniae, a human pathogen causing respiratory infections and probably
contributing to the development of atherosclerosis and heart disease, is an obligate intracellular …
contributing to the development of atherosclerosis and heart disease, is an obligate intracellular …
Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate?
MA Mariani, YJ Gu, PW Boonstra, JG Grandjean… - The Annals of thoracic …, 1999 - Elsevier
Background. Hemostasis is preserved after off-pump coronary operations compared with
conventional coronary procedures. However, this preserved hemostasis may result in a …
conventional coronary procedures. However, this preserved hemostasis may result in a …
Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches
…, ME Erasmus, F Zijlstra, MA Mariani… - European journal of …, 2010 - academic.oup.com
Chronic ischaemic mitral regurgitation (CIMR) remains one of the most complex and
unresolved aspects in the management of ischaemic heart disease. This review provides an …
unresolved aspects in the management of ischaemic heart disease. This review provides an …
[HTML][HTML] Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case
…, JM Musser, R Janulczyk, M Mariani… - Molecular & Cellular …, 2012 - ASBMB
We propose an experimental strategy for highly accurate selection of candidates for
bacterial vaccines without using in vitro and/or in vivo protection assays. Starting from the …
bacterial vaccines without using in vitro and/or in vivo protection assays. Starting from the …